Northwestern University and Osage University Partners both returned to back a $70m series B for Aptinyx, having previously contributed to a $65m series A round in May 2016.
Aptinyx, a US-based biopharmaceutical spinout of central nervous system life sciences firm Naurex, closed a $70m series B round yesterday that included Northwestern University and spinout-focused investment firm Osage University Partners (OUP).
The round was led by Bain Capital Life Sciences, while Adage Capital, Agent Capital, HBM Healthcare Investments, Partner Fund Management and Rock Springs Capital also participated. The round further featured Nan Fung Life Sciences, a subsidiary of property development group Nan Fung.
New Leaf Venture Partners, Frazier Healthcare…